The effect of risk factors on surgical and oncological results in high-risk prostate cancer: A multicentre study of the urooncology society, Turkey

被引:1
|
作者
Izol, Volkan [1 ]
Akdogan, Nebil [1 ]
Ozen, Haluk [2 ]
Akdogan, Bulent [2 ]
Kural, Ali Riza [3 ]
Tuna, Mustafa Bilal [3 ]
Sozen, Sinan [4 ]
Turkeri, Levent [5 ]
Tansug, Mustafa Zuhtu [1 ]
机构
[1] Cukurova Univ, Fac Med, Dept Urol, TR-01330 Adana, Turkey
[2] Hacettepe Univ, Fac Med, Dept Urol, Ankara, Turkey
[3] Acibadem Univ, Acibadem Maslak Hosp, Dept Urol, Istanbul, Turkey
[4] Gazi Univ, Fac Med, Dept Urol, Ankara, Turkey
[5] Acibadem Univ, Altunizade Hosp, Dept Urol, Istanbul, Turkey
关键词
RADICAL PROSTATECTOMY; SURVIVAL; MORTALITY; THERAPY; OUTCOMES; IMPACT; MEN;
D O I
10.1111/ijcp.14281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose To evaluate the effect of risk factors and selected surgical methods on operative and oncological results of patients undergoing radical prostatectomy (RP) with high-risk prostate cancer (HRPC). Methods Retrospective analysis of patients who underwent RP for HRPC from 13 urology centres between 1990 and 2019 was performed. Groups were created according to the risk factors of D'Amico classification. Patients with one risk factor were included in group 1 where group 2 consisted of patients with two or three risk factors. Results A total of 1519 patients were included in this study and 1073 (70.6%) patients were assigned to group 1 and 446 (29.4%) patients to group 2. Overall (biochemical and/or clinical and/or radiological) progression rate was 12.4% in group 1 and 26.5% in group 2 (P = .001). Surgical procedure was open RP in 844 (55.6%) patients and minimally invasive RP in 675 (44.4%) patients (laparoscopic and robot-assisted RP in 230 (15.1%) and 445 (29.3%) patients, respectively). Progression rates were similar in different types of operations (P = .22). Progression rate was not significantly different in patients who either underwent pelvic lymph node dissection (PLND) or not in each respective group. Conclusion RP alone is an effective treatment in the majority of patients with HRPC and PLND did not affect the progression rates after RP. According to the number of pre-operative high-risk features, as the number of risk factors increases, there is a need for additional treatment.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] The effect of body mass index on oncological and surgical outcomes in patients undergoing radical cystectomy for bladder cancer: A multicentre study of the association of urooncology, Turkey
    Izol, Volkan
    Deger, Mutlu
    Baltaci, Sumer
    Akgul, Murat
    Selvi, Ismail
    Ozden, Ender
    Suer, Evren
    Tansug, Mustafa Zuhtu
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (03)
  • [2] Oncological results of neoadjuvant chemohormonal therapy in patients with high and very high-risk prostate cancer
    Berkut, M., V
    Artemjeva, A. S.
    Reva, S. A.
    Tolmachev, S. S.
    Petrov, S. B.
    Nosov, A. K.
    ONKOUROLOGIYA, 2020, 16 (01): : 54 - 63
  • [3] Surgical treatment of high-risk prostate cancer
    Soares, R.
    Eden, C. G.
    MINERVA UROLOGICA E NEFROLOGICA, 2015, 67 (01) : 33 - 46
  • [4] High-risk prostate cancer: The oncological efficiency of radical prostatectomy
    Veliyev, E. I.
    Sokolov, E. A.
    Loran, O. B.
    Petrov, S. B.
    ONKOUROLOGIYA, 2014, 10 (01): : 53 - 57
  • [5] Results of surgery for high-risk prostate cancer
    Joniau, Steven
    Tosco, Lorenzo
    Briganti, Alberto
    Vanden Broeck, Thomas
    Gontero, Paolo
    Karnes, R. Jeffrey
    Spahn, Martin
    Van Poppel, Hein
    CURRENT OPINION IN UROLOGY, 2013, 23 (04) : 342 - 348
  • [6] Surgical management of high-risk, localized prostate cancer
    Wilkins, Lamont J.
    Tosoian, Jeffrey J.
    Sundi, Debasish
    Ross, Ashley E.
    Grimberg, Dominic
    Klein, Eric A.
    Chapin, Brian F.
    Nyame, Yaw A.
    NATURE REVIEWS UROLOGY, 2020, 17 (12) : 679 - 690
  • [7] Surgical management of high-risk, localized prostate cancer
    Lamont J. Wilkins
    Jeffrey J. Tosoian
    Debasish Sundi
    Ashley E. Ross
    Dominic Grimberg
    Eric A. Klein
    Brian F. Chapin
    Yaw A. Nyame
    Nature Reviews Urology, 2020, 17 : 679 - 690
  • [8] High-risk prostate cancer: the role of surgical management
    Morlacco, Alessandro
    Karnes, R. Jeffrey
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 102 : 135 - 143
  • [9] Review of the article "Oncological results of neoadjuvant chemohormonal therapy in patients with high and very high-risk prostate cancer"
    Nyushko, K. M.
    ONKOUROLOGIYA, 2020, 16 (01): : 64 - 65
  • [10] OUTCOMES OF SURGICAL MANAGEMENT OF LOCALIZED HIGH-RISK PROSTATE CANCER: RESULTS FROM THE PROSTATE CANCER CANADIAN COLLABORATION
    Ory, Jesse
    Breau, Rodney
    Saad, Fred
    Kassouf, Wassim
    Shayegan, Bobby
    Duplisea, Jonathan
    Lawen, Tarek
    Morash, Christopher
    Aprikian, Armen
    Rendon, Ricardo A.
    JOURNAL OF UROLOGY, 2018, 199 (04): : E815 - E815